IDYA Stock Analysis: Buy, Sell, or Hold?

IDYA - IDEAYA Biosciences, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$30.23
1.25 (4.31%) ▲
5d: -3.97%
30d: +4.82%
90d: -13.11%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 04, 2026

Get Alerted When IDYA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: IDYA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: IDYA is currently trading at $30.23, which is considered oversold relative to its 30-day fair value range of $28.03 to $29.55.

Technical Outlook: Technically, IDYA is in a strong downtrend. Immediate support is located at $26.81, while resistance sits at $31.95. The stock is showing strong short-term momentum, up 4.3% recently.

Market Sentiment: IDYA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $51.69 (+78.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $28.03 - $29.55
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 100.0%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.3%)
  • BULLISH: Trading 78.4% below Wall St target ($51.69)

Trading Range Analysis

30-Day Trading Range $28.03 - $29.55
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $26.81
Resistance Level $31.95
Current Trend Strong Downtrend
Technical data as of Jun 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) -7.77
Wall Street Target $51.69 (+78.4%)
Revenue Growth (YoY) 55.4%
Profit Margin -62.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 15, 2026 4:32 PM ET
Data refreshes hourly during market hours. Next update: 5:32 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jeffrey Stein BUY 50000 shares 2026-03-02

Unlock Insider Activity

See real-time buying/selling by company executives for IDYA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 52 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 50 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$275 61 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$103 58 HOLD

More Analysis for IDYA

IDYA Technical Chart IDYA Price Prediction IDYA Earnings Date IDYA Investment Advisor IDYA Fair Price Analyzer IDYA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals